tirzepatide and progesterone Postmenopausal women on the GLP-1 medication (Zepbound) for obesity lost more weight if they were also using menopause hormone therapy, a retrospective cohort study indicated. https://www.medpagetoday.com/endocrinology/menopause/119594 Tirzepatide and Hormone Replacement Therapy

Refills also provide medical support throughout the treatment to track progress and address any adjustments needed

Special populations and considerations Different patient populations have different considerations when it comes to choosing between insulin and GLP-1 therapy

Lyme disease is the most common vector-borne disease in the USA and is a global issue

Strength training and movement Exercise can support metabolic health and appetite balance

Although GLP-1 might enhance bone metabolism and quality, the impact of these receptor agonists on bone health remains uncertain and is the subject of this review

Brain access of incretins and incretin receptor agonists to their central targets relevant for appetite suppression and weight loss